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•9"d'• Enalapdl (EN) Improves Alveolar-Capillary 
Diffusion In Chronic Heart Failure (CHF) and 
Aspirin (AS) Contrasts This Effect 
Marco Guazzi, Pier G. Agestonl, Gian C. Marenzi, Gian R Laud, 
Emilio Assanelli, Maudzio D. Ouazzi. University of Milan, M#an, italy 
Prestaglaedins (PGs) participate in the local control of transcapillary fluid flux 
and interstitial volume. ACE is concentrated in the lung vessels and ACE- 
inhibitors expose them to enhanced formation of PGs. Were PGs involved 
in the regulation of extravascular lung fluid, ACE inhibitors and AS would 
probably exert an opposite therapeutic action in CHF, where lung fluid plays 
a pivotal role. To probe this assumption 15 CHF patients (111, NYHA), treated 
with digoxin and furosemide, received {random and double-blind) placebo 
(PL), EN (20 rag), AS (325 rag), EN + AS, for 15 days each. Vitol capacity 
(VC), maximal voluntary ventilation (MW), lung diffusing capacity (DLCO) 
and oxygen consumption (VO2p), ventilation (VEp), tidal volume, (VTp), dead 
space/tidal volume ratio (VDNT) at peak exercise were tested at the end of 
each step. 
vo2 p VE D ~ p VDNT MW VC DLCO 
PL 15.0 47.9 1.49 0.23 89 3.1 22 
4-5 :1:15 ±0.4 4-0.6 ~24 ~7 4-7 
EN 18.8 64 1.71 0.20 104 3.2 24 
4- 4°~ 4-12 *#§ 4- 0.3"#~ 4- 6*§ 4- 21 * 4- 6 4- 6 °~ 
AS 15.8 50 1.50 0.24 93 3.0 22 
d:4 4-15 4-0.3 4-0.6 4-21 4-7 4-7 
EN + AS 16.7 54.8 1.54 0.22 103 3.1 22 
4-4 4-12 4-0.9 4-0.5 4-24* 4-6 4-7 
Mean~ .4- SD, *p < 0.05 vs PL; §p < 0.05 vs AS; #p < 0.05 vs EN + AS 
Conclusions: a) Changes in DLCO and lung mechanics with EN are con- 
sistent with modulation of lung interstitial f .id, ameliorating respiratory and 
functional capacities; b) PG stimulation seems to undedie these actions as 
they are counteracted by a PG inhibitor. 
C-Myc Expression Relates to Decrease in 
Myocardial Contractility in Patients Wdh Chronio 
Aort ic Rogurgitation 
Satoshi Taketant, Kazuhiro Taniguchl, Yoshikl Saws, Keiji Kedoba, 
Masataka Mitsuno, Hikaru Mstsuda, Shunzo Onishi ~, 
Naomasa Kawaguchi ~ . r 1st Depf of Surg, School of Allied Health Science, 
Osaka Univ., Osaka, Japan 
In patients with end-stage aortic regurgitation (AR), excess of volume-load 
on the left ventricle (LV) cause congestive heart failure associated with a 
decrease in LV contractility. Recently, proto-oncogenes have been implicated 
in the pathogenesis o! myocardial remodeling resulting in a decrease in LV 
contractility. However, in human heart, it has never been clarified whether 
C-Myc may relate to contractile impairment and structural alteration. In the 
present study, the expression of C-Myc in myocardium were examined in 
patients with AR. Nine patients (7 male and 2 female) aged from 31 to 70 
years (mean, 52.9 ± 13,4) with Isolated chronic AR underwent aortic valve 
replacement. Preoperative NYHA class was Ifl in 5 patients and IV in 4. 
Ejection fraction of LV (EF)(49.2 ± 11,6%), end-systolic volume index of LV 
(ESVI)(87,4- 30 ml/m 2) and left ventricular mass index (LVMI)(183 :1: 34 g/n~) 
were measured before surgery. The specimens of LV muscle were obtained 
by endomyocardial biopsy dudng aortic valve replacement. Expression of C- 
Myc were evaluated by Immunohistochemlcat staining. All patients howed 
significant higher values in nw.. ocardial cell diameter (CD)(33.1:1:11.8 p.m)and 
fibrous content (FC)(26.5 + 13.2 g/m ~) than did the non~al control. C- 
Myc(28.3 4- 16,1=/o) was detected in these patients while, it has never been 
detected in normal control. ESVI were inversely correlated with EF(r = 0,94 
p < 0.01), CD (r = 0.93 p < 0.01) and FC(r = 0.95 p < 0.01). C-Myc showed 
inverse correlation with ESVI(r = -0.87 p < 0,05), CD(r == 0.96 p < 0.01) and 
FC(r = 0.92 p < 0.01). These results demonstrated that C-Myo expression 
relate to extensive cellular hypertrophy and interstitial fibrosis and inversely 
relate to ESVI in patients with chronic aortic regurgitation. This suggest hat 
C-My,: may relate to cardiac remodeling, and its dewn-rngulatlon may be 
associated with the decrease in LV contractility. 
~ Differences in Temporal Risk 01 Sudden end 
Nonsudden Death In Patients With End.b~mge 
Heart Failure Listed for  Cardlec Transplantation 
Michael O. Sweeney, John B. Newell, Hasan Garan, Bdan McGovem, Marc 
J. Semigran, Jeremy N. Ruskin. G. William Dec. Massachusetts General 
Hospital, Boston, MA 
Sudden death (SD) is a malor threat to survival in patients with end-stage 
heart failure awaiting cardiac transplentation, Current pdodtizatldn of rectlP 
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lent need for transplantation is based or" critena relating to hemedynamic 
compensation and risk of nonsudden death (NSD). Similar cdteria for strati- 
fying risk of SD do not exist and the temporal pattern of SD risk is unknown. 
We compared actuadal SD and NSD mortality rates in 162 patients listed for 
transplantation using lifetable analysis. There were 43/162 (26.5°/'0) cardiac 
deaths [23(14.2%) sudden and 20(12.3o/=) nonsudden] during mean followup 
15,8 ± 18.3 months. Hazard functions dedved from lifetable analysis were 
plotted as a function of time and the equations of the best-fit lines were 
calculated by linear egression (Figure), 
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The slope of the hazard fur, ction curve expresses the change in (probability 
of death/month per month) independent of censored events (transplantation). 
The SD Slope was positive (+0.03 ± 0.01, R = 0.81, p = 0.04) and the 
NSD slope was negative (-  0.05 ± 0.01, Time (months) after listing R = 
0.92, p = 0.01) consP~ ent with progressively increasing versus progressively 
decreasing rates of change in risk, respectively. 
Condusions: In patients with end-stage heart failure listed and awaiting 
transplantation, the risk of NSD decreases over time, while in contrast, the 
risk of SD increases over time. 
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F9-6~--6"9-] Contribu|ion of  Coronary Vasoconstriction to 
Myocardial Blood Flow Changes Induced by 
Physiologic Stresses 
Asif Rehmen, Anastasia N. Kitsiou, Stephen L Bacharach, Clalbome 
M. Davis, Vasken Dilsizian, Arahed A. Quyyumi. NIH, Bethesda, MD 
Atherosderotic coronary artedes constrict in response to exercise (EX). We 
investigated the impact of coronary vasoconstriction  regional myocardial 
blood flow (MBF) in normal and ischemic zones dudng physiologic stresses 
incluoing bicycle EX. r,'tental stress (MS) using a video game, and compared 
it with adenosine (ADG). Seven men (age 60 -~ 10 years; 5 with 2- and 2 with 
3-vessel CAD} had MBF estimated from N-13 ammonia uptake normalized 
to absolute flow in one sector using PET. All lots had normal eft ventdcu- 
let function (ejection fraction 58 4- 8%) and EX-induced thallium perfusion 
defects. Ischemic segments were defined as regions where ADO.induced 
MBF increase was < 90% of normal segments (supplied by unobstructed 
corenades). MBF changes with EX and MS were compared with ADO in 171 
normal and 101 ischemic segments. (MBF in ml/min/g) 
Rest ADO MS EX 
MBF (Normal zones) 0.82 2.6 1.2 1.7 
MBF (Ischemic zones) 0.75* 1.9"° 1.1 * 1.3" 
*p < 0,05, **p < 0.01 
MBF was lower in ischemio segments at rest, and after MS and EX. De* 
spite development of ischemia (ST depression) dudng EX which would be 
expected to maximize blood flow, MBF in the Iscbemic segments remained 
29% below the level achieved with ADO (that measures flow reserve). SimF 
lady, during MS, MBF in iechemio segments was lower than in normal areas. 
and much lower than ADO, suggesting that coronary vaseconstdction i  is- 
chemic regions occurs dudng both EX and MS. Thus, vaseconstdction of 
coronary stenoses dudng EX and MS causes significant attenuation in MBF 
increases to ischemic regions. Whether these changes can be reversed by 
antiar, gtnal medications needs to be further investigated. 
~-5~ Ro~ ot Bml Coronsry Tone in vesos~=e.= 
Angina 
Yuk(o Ozaki, David Keane, Patrick W. Senuys. Catheterfzat,ion Laboratory, 
Thoraxcanter, Erasmus University Rotterdam, NL 
Previous attempts to determine the vole of' basal coronary tone in the patho- 
physiology of vadant angina have produced conflicting evidence. We ex- 
amined the vasoconstrictor response to ergnnnvine and the vasodilator e- 
sponse to isosorbide dinitrate (basal coronary tone) at spastic and non- 
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spastic coronary segments in 31 patients undergoing sedal angiographio 
follow-up of vadant angina. Coronary angiograms and erg0novine provoca- 
tion tests were repeated at an interval of 45 months. While all 31 patients 
demonstrated a positive response to ergonovine initially, vasospastic respon- 
siveness persisted in only 16 patients at follow-up (Group 1) and resolved 
in the other 15 patients (Group 2). Mean luminal diameter of entire coronary 
AHA segments in a total of 170 normal or near normal coronary segments 
were measured, using a quantitative angiography analysis system (CAA$ 
II). In active vasospastio anginal period (initial and follow-up angiograms in 
Group 1, and initial angiogram in Group 2) basal tone was significantly higher 
at spastic segment than nonspastlc segments. In inactive period (follow-up 
angiegram In Group 2) basal tone was not different between previous pastic 
and nonspastio segments. The diagnostic sensitivity and specificity at 20% 
elevation of basal tone for the prediction of vasospasm were 77°/,, and 73%, 
respectively. 
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Coronary artery tone may change in proportion to the activity of variant 
angina over several years. Contrary to some previous studies, the estimation 
of basal coronary tone may be useful in the assessment of vasospastic 
activity in patients with variant angina. 
~ " ~  Eosinophil  Mediated Immunological Mechanism 
and inflammation In Vaeospastic Ang ina- -  Novel 
Coronary Risk Factor for Coronary Spasm 
SeiJl Umemoto, Nodko Minamlsono, Takahiro Iwami, Takahito Yonezawa, 
Akihisa FuJii, Takashi Fujii, Masunod Matsuzaki. YamagLchi Univ. Ube, 
Japan 
Vasospastic angina (VSA) is caused by corunary spasm. However, the mech- 
anism of VSA is yet unclear whether other mechanisms, such as inflammation 
or immunological mechanisms may cause vasospasm. In addition, recent 
studies suggested the mast cell-macrophage interaction and IgE-mediated 
atherosclerosis. To clarify the immunological mechanism in VSA, we com- 
pared hematologic values, blood chemical values, fibrinogen, C-reactive 
protein (CRP), and coronary risk factors such as cholesterol and HDL-C in 
VSA patients (pts) (n : 24) with those in stable effort angina pectoris pts 
(sAP, n : 17). 
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We also compared the relationships between all parameters examined 
and the severity in symptoms (mila; nitroglycerin (NTG) effective and short 
duration attack, n = 13, severe; NTG not effective, long duration attack and 
severe arrythmia, n = 11) in VSA. T':ero were no significant differences 
in coronary dsk factors, bo¢ly temperature, white blood cell court, CRP and 
llbrinegen between sAP and VSA. However there was a significant difference 
in eosinophll count between sAP and VSA. (sAP =, 108 :t: 48/ram a, VSA = 
254 -v 1141mm3; p = 0.0001). There were also significant differences both in 
fibdnogen p - 0.012) and eosioaphit (p = 0.0001) between mild (309 ± 82 
mg/dl, 178 + 69/mn~, respectively) and severe VSA (448 :t: 53 mg/dl, 344 
± 86/ram a. respectively). These results suggest that eosinophil-mediated 
immunological mechanism and inflammation may play an important role in 
the pathogenesis of VSA. In addition, eoslnophil court and fibrtnogen may be 
a detomlinant factor for the severity of VSA. 
F9-• - ]  Why is Onset of  Acute Infarction Myocardial Uncommon In Patients Wilh Vaeospastic Angina? 
Kyoichi Mizuno, Shirmlchi Ohkun!, Shinnya Yokoyama, 
Toshiyukl Kobayashi, Tedasn! Yamagishi, Hirokuni Etsuda, Kimio Satomura, 
Koh Arakawa, Toshio Shibuya. Chfl:;o Hokt,~;c,,'; Hospital Nipp¢, ~, Medica! 
School, and National Defense Medical College, Chiba and Saitama, Japan 
Vr~sospasm ay theoretically rupture plaque by compressing the atheroma- 
t;;us plaque. Nevedhe!ess, onset of myocardial infarction is uncommon in 
patients with vasospastio angina in contrast o unstable angina. Therefore, 
to clarify the differences of pathophysiology between two groups, we inves- 
tigated intralumlnal changes by coronary angioscopy. Twenty three patients 
with vasospastic angina and 24 with unstable angina were enrclled in the 
present study. Coronary angioscopy was performed at the site of coronary 
vasospasm immediately after drug induced or spontaneous coronzcy va- 
sospasm in patients with vasospastic angina and at the culpdt lesion within 
48 hours after an episode of pain at rest in those with unstable angina• Intima! 
injuries (intimal flap, ulceration, dissection, hemorrhage) were observed in 
the 8 patients with vasospastic angina and in the 14 with unstable angina 
(35% vs. 58%, n.s.). Xanthomatous plaques were observed in the 13 (54%) 
patients with unstable angina, but were not seen in any of the 23 patients with 
vasospastio angina (p < 0.001). White plaques were ,~een in all patients with 
vasospastic angina and in the 11(46%) with unstable angina (to < 0•001). In 
conclusion: 1) As lipid dch xanthomatous plaque is thrombogenic, the differ- 
ent character of plaque between two groups can account for the contrasting 
results of onset of acute myocardial infarction. 2) Although vasospasm may 
provoke intimal nJudes, less existence of thrombogenic plaque in patients 
with vasospastic angina does not induce the onset of acute myocardial in- 
farotion. 3) Angiosccpy can provide a new understanding of pathogenesis in 
coronary artery disease. 
V~'~'@ Altered and Circadian Variation of  Determinants 
Transient Myocardial  Ischemla in Unstable Angina 
and Non-Q Wave MI 
Deven J. Petal, Diana R. Holdright, David Mulcahy, Chades J. Knight, 
Dabble Clarke, Christine Wdght, Henry Purcell, Kim Fox• Royal Brompton 
Hospital, London, UK 
Thrombosis and coronary vasospasm may play a greater ote in the genesis 
of transient myocardial ischemia (TMI) in unstable angina (UA) and non- 
Q wave MI (NQ) than increased myocardial demand and may therefore 
have a different circadian variation to TMI in stable coronary disease. Using 
continuous ECG monitoring, the heart rate (HR) changes prior to and onset 
of TMI, and its circadian variation were assessed in 256 patients with UA and 
NQ whilst on stsndardised therapy. A 5 beat HR increase 10 rain. pdor to TMI 
was defined as representing increased myocardial demand. 132 episodes of 
TMI occurred in 32 (15.1%) UA LOts, and 44 episodes in 12 (27.3%) NQ pts (P 
= NS), with a mean HR at onset of 67.7 ± 12.7 and 70.5 ± 13.0 respectively 
(P = NS). HR increased pdor to TMI in 45% of episodes in UA, and 41% in 
NQ (P = NS). TMI activity was greatest between 10 pm to 8 am in UA and NQ 
(P < 0.05), and was evident for silent TMI as well ~ symptomatic episodes, 
irrespective of the preceding heart rate changes. 
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Conclusion: TMI in UA and NQ is associated with increased myocardial 
demand in less than half of the episodes and occurs most commonly at night 
when pro-coagulant activity and vasomotor tone are increased. This has 
implications on the choice and timing of any additional therapeutic agents. 
~ T h e  Effect o f  Acute Versus Chronic Angina on the 
Quality of  Life Change== After Ang iop lu ty  
Gary S. Ledlay, William Hirec.h, Antoinette Dowds, Dawn ~ n ,  Morris 
N. Kotler. At#err Einstein Medical Center, Ten3~ University School of 
Medicine, Phlladelr~.la, PA 
PTCA has been shown to be clinically ~ective in pa~Its both with acute 
and chronl¢ angina. However, the alfoct of PTCA on Quality of Lifo (QOL) 
¢ltang~ in patients with acute or ctvor~ asgina has not baser evaluate. 
Therefore, the ~ Oulcomes Study (MOS.36), a well validated, quart- 
tttalJve tool 1o measure OOL was edministered to 113 consecutive pa3ents, 
